Muscle & mechanical loading
Isometric Handgrip Training
Graded on: resting systolic blood pressure (surrogate, objective).
Grade C: human trials exist, but they are small, mixed or not yet repeated. This is not a finding that it does not work. How to read a grade →
At a glance
Isometric handgrip training means squeezing a hand gripper and holding the squeeze for about two minutes at a time, several times a week. Studies that pooled small trials found the top blood pressure number fell a few points. But the one trial that compared it with a fake, very light squeeze found no change, and 24-hour blood pressure monitors mostly showed no change either. Blood pressure is a stand-in measure, not heart attacks or strokes.
- What was measured
- Resting blood pressure in adults with high-normal or high blood pressure who squeezed a handgrip device in timed holds.
- How big
- Pooled trials found systolic pressure 6.7 mmHg lower than control, but the only trial with a dummy grip and a blinded home trial found no change.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 36379974.
- Who it applies to
- Adults with high-normal pressure or hypertension, most on blood pressure medicine.
- Safety
- The record lists no specific safety warnings for this use.
- Compared with
- No exercise or usual care in most trials; one trial used a dummy grip at very low effort.
- Certainty
- Grade C, resting on: Randomized trials and meta-analyses A study that pools the numbers from several trials into one combined estimate. of randomized trials.
- What would change this grade
- Could rise to B with: Two or more randomized controlled trials People are assigned to the treatment or a comparison by chance, so the groups differ only in what they received. It is the design that can show cause and effect. of handgrip training against a sham A fake version of a procedure or device used as the comparison, so participants cannot tell which one they received. grip at very low load, run by independent groups, with blood pressure read by assessors blinded to treatment. Who: Adults with high-normal pressure or untreated stage 1 hypertension, at least 150 per arm. Measured: 24-hour ambulatory systolic blood pressure, with office pressure as a secondary measure. Length: At least 12 weeks.
- Cost
- No price recorded yet.
- Sources
- 11 studies cited on this record, listed under Sources.
A letter describes the human evidence, not the product, the manufacturer, or the intervention's worth.
See the full evidence record →Isometric Handgrip Training, graded on resting systolic blood pressure (surrogate, objective): what the randomized trials measured, in whom, and what they did not show.
Why this letter
Why this gradeGrade C, small or unreplicated trials. The reasoning, and what the grade does not cover.
Grade C on resting systolic blood pressure in adults, most with high-normal pressure or treated hypertension. Pooled analyses of small trials find office systolic pressure about 4 to 8 mmHg lower than control (Oliveira et al., 2023; PMID 36379974; Almeida et al., 2021; PMID 34140663; Liu et al., 2026; PMID 42289678). The only trial with a sham handgrip arm found no change in office or 24-hour pressure (Pagonas et al., 2017; PMID 28622156), an assessor-blinded home trial found no benefit over usual care (Danielsen et al., 2023; PMID 38166533), and pooled 24-hour ambulatory readings did not change (Oliveira et al., 2024; PMID 39185910). Mixed results with null controlled trials meet the written C definition.
WHY NOT BB needs a good trial supported by further trials, and the trials with a sham arm or blinded assessors did not find the effect. Blood pressure is a surrogate, so B would be the ceiling in any case.
WHAT THIS GRADE DOES NOT COVERheart attack, stroke or death, which no trial measured; grip strength as a marker of health, which is observational Research that watches what people already do rather than assigning a treatment. It can show that two things travel together, not that one causes the other. and belongs with the biomarkers A measurable sign in the body, such as a blood test value, used to track a condition or the effect of a treatment.; and any specific device, since spring grippers and electronic devices were both used.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Evidence notes: meta-analysis, randomized trial
Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Resting systolic blood pressure (surrogate, objective) (surrogate)
Last reviewed: October 2026
The trial that would change this grade.
A positive trial of this shape, supported by further trials, would move this entry to B.
Why the current trials fall short
Blood pressure is a surrogate, so B is the ceiling. The sham-controlled trial that exists was null; independent sham-controlled trials of adequate size showing lower 24-hour pressure would be needed to move the letter.
Why people believe itTwo human sources; no published case reports of benefit; no reports of harm.
The case for handgrip training is that a few minutes of squeezing, three times a week, is cheap, safe and possible for people who cannot do aerobic exercise, and several pooled analyses report lower office blood pressure. Some guidelines list isometric exercise as an option for blood pressure.
What supporters point to, and what each source actually shows. None of it is enough to move this letter higher; the trial described above under Evidence wanted is what would.
- Human trial, the use graded hereIn 30 older adults with hypertension, 8 weeks of home training with an inexpensive spring gripper lowered office systolic pressure 8.2 mmHg more than squeezing without resistance. A small trial on office readings. PMID 41779689
- Human trial, the use graded hereA pooled analysis of 20 trials, 626 participants, found systolic pressure 4.1 mmHg lower than control, largest in people with high-normal pressure. It mixed randomized and non-randomized trials. PMID 42289678
A case report describes what happened to one or a few patients. It cannot show the treatment caused the change, and reports of success are published more often than reports of failure.
A PubMed search in October 2026 found no published case report of benefit for this use.
Searched PubMed, October 2026: 20 case report record(s) returned. None describes handgrip training for blood pressure. Most use the handgrip as a diagnostic stress test in heart disease; the rest concern rehabilitation, athletes and other topics. No benefit or harm report on this use was found.
ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Isometric Handgrip among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.
Search recruiting studies of Isometric Handgrip on ClinicalTrials.gov
Dose, form and timing
Resting office blood pressure at baseline and after 8 to 12 weeks, measured the same way each time, ideally with home or 24-hour readings as well, since the trials that used 24-hour monitoring mostly found no change. Grip strength at baseline sets the training load: the trials used 30% of maximal voluntary contraction.
As studiedDose, form, population and duration for every use.
A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.
Safety
No safety data. Each caution on this record, sorted by what it rests on.
None recorded.
None recorded.
None recorded.
None recorded.
No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.
Grade history
How this letter has changedLatest: No. 376 · October 2026 · First graded.
The isometric handgrip training record, added in August 2026, was missing from the data file while the grip strength dynamometer record still pointed to it as a separate graded therapy. It is rebuilt from a new PubMed search. Pooled analyses of small trials find office systolic pressure about 4 to 8 mmHg lower (Oliveira et al., 2023; PMID 36379974; Almeida et al., 2021; PMID 34140663; Liu et al., 2026; PMID 42289678). The only trial with a sham handgrip arm was null for office and 24-hour pressure (Pagonas et al., 2017; PMID 28622156), an assessor-blinded home trial found no benefit over usual care (Danielsen et al., 2023; PMID 38166533), and pooled ambulatory readings did not change (Oliveira et al., 2024; PMID 39185910). Mixed results with null controlled trials: Grade C, the same letter the record held in August. Applied the written grade definition under the editor's standing instruction of October 2026 (Arnold Sandlow, D.C.).PMID 36379974 PMID 34140663 PMID 42289678 PMID 28622156 PMID 38166533 PMID 39185910
Every change to a letter on this site is dated and published. The full evidence log →
Sources
- Citations
- Every paper cited on this page is matched to its PubMed record on every build.
- Retractions
- None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
- Read against the papers
- October 2026. By the EBL editor, Arnold Sandlow, DC.
- Outside review
- Not yet done. No reviewer outside EBL has checked this record.
What each of these checks can and cannot show: evidence integrity.
Primary evidenceEleven papers, each linked to its PubMed record.
Oliveira et al. (Journal of Human Hypertension, 2023; PMID 36379974): 7 randomized trials of handgrip training in adults with hypertension, systolic pressure 6.7 mmHg and diastolic 4.5 mmHg lower than control. Almeida et al. (Hypertension Research, 2021; PMID 34140663): 5 trials, 324 medicated hypertensive adults, systolic 8.1 mmHg lower, diastolic unchanged. Liu et al. (BMC Public Health, 2026; PMID 42289678): 20 trials, 626 participants, randomized and non-randomized, systolic 4.1 mmHg and diastolic 2.3 mmHg lower. Kelley and Kelley (Journal of Hypertension, 2010; PMID 20009767): 3 trials, 81 participants. Against these: Pagonas et al. (Journal of Hypertension, 2017; PMID 28622156), 75 adults with hypertension, 12 weeks, handgrip at 30% of maximum against a 5% sham: no change in office or 24-hour pressure, while aerobic exercise lowered both. Danielsen et al. (Journal of Sports Sciences, 2023; PMID 38166533), 48 adults, 20 weeks of home training, assessors blinded: not superior to usual care. Oliveira et al. (Journal of Cardiopulmonary Rehabilitation and Prevention, 2024; PMID 39185910), pooled ambulatory trials: no change in 24-hour systolic pressure, awake diastolic 2.0 mmHg lower. Smaller trials: Palmeira et al. (Sao Paulo Medical Journal, 2021; PMID 34787298), 63 patients in primary care, office systolic lower, ambulatory unchanged; Oliveira et al. (Clinical Physiology and Functional Imaging, 2026; PMID 42928564), 67 medicated adults, awake ambulatory pressure lower after 4 weeks, 24-hour unchanged; Champaiboon et al. (PLoS One, 2026; PMID 41779689), 30 older adults with hypertension, spring device against non-resistive squeezing, systolic 8.2 mmHg lower; Millar et al. (Journal of Cardiopulmonary Rehabilitation and Prevention, 2008; PMID 18496321), an inexpensive spring device. Mixed results with null controlled trials: Grade C.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
("isometric handgrip"[tiab] OR "handgrip training"[tiab] OR "hand grip training"[tiab] OR "isometric hand grip"[tiab] OR "handgrip exercise"[tiab]) AND ("blood pressure"[tiab] OR hypertension[tiab] OR hypertensive[tiab]) AND (meta-analysis[pt] OR randomized controlled trial[pt] OR systematic review[pt])PubMed watch: does a new study change the grade? (nothing new)
No new paper matching the search behind this grade has been added to PubMed since October 2026.
Last run October 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.
Disclosure
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
This page carries a letter. No letter has been bought and none is for sale. Products listed under this modality may be commercial partners, and their purchase links may earn EBL a commission. Those products carry no letter of their own, every relationship is disclosed beside the link, and where a product does not deliver what the trials tested, this page says so regardless of who pays.
How this is enforced
That is not a promise, it is a build condition. Two checks run on every deploy: one refuses to publish if a page says EBL earns a commission on anything that carries a letter, the other refuses if a page names a commercial relationship that is not declared in the register. If either fails, this page does not go live. You can read how the checks work, and what they do not cover, on the evidence integrity page.
© Evidence Based Longevity, Inc. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →